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Abstract
Objectives—To identify risks for mesh/suture erosions following sacrocolpopexy (ASC).
Study Design—We analyzed demographic, perioperative variables and erosion status in 322
participants in the Colpopexy and Urinary Reduction Efforts study two years after
sacrocolpopexy.
Results—The predominant graft used was synthetic mesh; Mersilene (42%) or Polypropylene
(48%). Twenty subjects (6%) experienced mesh/suture erosion. Unadjusted risk factors for mesh/
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suture erosion were expanded polytrafluroethylene (ePTFE) mesh (ePTFE 4/21 (19%) versus non-
ePFTE 16/301 (5%): OR 4.2), concurrent hysterectomy (OR 4.9) and current smoking (OR 5.2).
Of those with mesh erosion, most affected women (13/17) underwent at least one surgery for
partial or total mesh removal. Two were completely resolved, 6 had persistent problems and 5
were lost to follow-up. No resolution was documented in the 4 women who elected observation.
Conclusions—Expanded PTFE mesh should not be used for sacrocolpopexy. Concurrent
hysterectomy and smoking are modifiable risks for mesh/suture erosion.
Keywords
Expanded polytrafluroethylene (Gore-TexR®); Mesh Erosion; Sacrocolpopexy; CARE Trial;
hysterectomy
Introduction
Abdominal sacrocolpopexy (ASC) is a commonly performed procedure for the surgical
treatment of apical pelvic organ prolapse. Surgeons who favor this technique rely on its
well-established success rates ranging from 78-100% and durability, which is attributed to
reinforcement of native tissues with a graft. [1] Despite recognition of the risk of erosion,
synthetic graft materials have been preferred over autologous grafts for ASC because they
are durable, avoid the morbidity and operative time of harvesting fascia, are readily
available and are relatively inexpensive. Ideally, these benefits should outweigh the
possibility of erosion, a unique complication of using a graft.
Sacrocolpopexy mesh erosion is typically evident by exposure of the graft in the vagina. In
such cases, granulation tissue and a sero-purulent or sero-sanginous discharge is usually
present. This may be accompanied by pain or tenderness and dyspareunia. [2] Occasionally
the sacrocolpopexy vaginal sutures may be the only visible foreign material. In the absence
of visible graft, some investigators prefer the term suture erosion.
The pathophysiology of these materials complications is not known and not implied by the
word “erosion”, used here to indicate an unplanned exposure of surgical materials. Erosion
may result from an inflammatory reaction due to infection of the foreign body or, possibly,
due to an immunological response to the graft or suture material. Alternatively, the mesh or
sutures may be exposed without an obvious inflammatory reaction and can be relatively
asymptomatic. Nevertheless, the management of erosions has a significant occurrence of
major complications.[3,4]
A recent sacrocolpopexy literature review reported a median rate of 3.4% for synthetic mesh
erosion, with rates varying depending on which grafts were used (0% with biologic grafts;
0.5% with polypropylene mesh; to 5.5 % with Teflon mesh).[1] No definite conclusions
could be made regarding whether specific graft types were more likely than others to
predispose recipients to erosion because other variables such as method of graft placement,
concurrent hysterectomy, and various demographic differences were infrequently available
for analysis. Other reports also link erosion to the type of mesh used and method of
placement without identifying other risk factors. [2,5]
The Colpopexy andUrinary Reduction Efforts (CARE) trial provides an excellent
opportunity to look for potential risk factors for mesh/suture erosion in a large cohort of
well-described patients that underwent a sacrocolpopexy with standardized physical exams
at set intervals during the two-year follow-up. Our objective was to identify demographic
and surgical parameters associated with foreign body complications of the ASC specifically
mesh and suture erosion.
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The CARE trial was a randomized surgical trial of 322 stress continent women with Stages
II to IV pelvic organ prolapse conducted to investigate the benefit of an adjuvant Burch
colposuspension at the time of sacrocolpopexy. The study was designed and implemented by
the Pelvic Floor Disorders Network (PFDN), a consortium of clinical sites and one data
management center funded by the National Institute of Child Health and Human
Development. Each clinical site and the data-coordinating center received institutional
review board approval and all women provided written informed consent. We previously
reported the CARE trial methods,[6] three-month outcomes,[7] and global two-year
outcomes.[8]
This prospectively planned analysis included baseline, surgical and post-operative outcome
data, as well as complication and safety data collected throughout the 2-year postoperative
follow-up period. Demographic and medical history data were collected by interview at
baseline. Participants underwent the a standardized Pelvic Organ Prolapse Quantification
(POP-Q) examination [9] at baseline, the 6 weeks, 3 months, 12 months and the 2-year
postoperative visit. A speculum exam to screen for mesh or suture erosion was performed at
each post-op visit.
Sacrocolpopexy via laparotomy was the clinically selected surgery whereas the Burch
colposuspension was the research procedure in the CARE trial. Therefore, the study
permitted variations in ASC technique that were not thought to influence the primary and
secondary outcomes. Such variations included the type of laparotomy incision and
configuration of the graft (recorded as conical, two-strap, Y, fingered or other
configurations. Selected graft and sutures material (from a list generated during study
inception that reflected their common clinical practice) included autologous tissue (such as
rectus fascia or fascia lata), synthetic material including woven polyester, (Mersilene™,
Ethicon Inc, Sommerville NJ), polypropylene (, Prolene™ Ethicon Inc, Sommerville NJ),
soft weave polypropylene (Gynemesh ™ Ethicon Women's Health & Urology, Cincinnati)
and expanded polytrafluroethylene (ePFTE) (Gore-Tex®, GORE™ Medical, Newark DE)
or Trelex™), allograft material (such as cadaveric rectus fascia or fascia lata) and xenograft
material such as hexamethylene diisocyanate cross-linked porcine dermis (Pelvicol ™ CR
BARD, Murray Hill, NJ). Synthetic absorbable material (such as polygalactin mesh) was not
allowed.
Graft material was sutured to both the anterior and posterior vaginal walls and then anchored
to the anterior longitudinal ligament of the sacrum in such a way as to avoid tension on the
anterior portion of the graft. A minimum of two stitches was used to secure the graft
material to the sacrum. The type, gauge and number of stitches used on the vaginal and
sacral ends of the grafts were recorded and characterized as interrupted or continuous. Other
technical aspects of the sacrocolpopexy procedure, including performance of concurrent
procedures for anterior and posterior prolapse, culdoplasty, and reperitonealization were left
to surgeon preference but were recorded. Because of the potential impact on the primary
outcome, stress incontinence, subjects were stratified by the intent to perform a paravaginal
repair (done at the surgeon's discretion and disclosed before randomization) as well as by
surgeon.
Adverse events forms were completed for each episode of mesh or suture erosion and were
updated after any procedure or treatment for this complication. All adverse event (AE)
forms were completed and signed by the study surgeon who assigned intensity, causality
with respect to study surgery or concomitant procedures and outcome or resolution. The
DCC generated regular reports for the Data Safety and Monitoring Board (DSMB). In
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February 2005, the DCC noted that 4 of the first 5 reports of mesh/suture erosions were
received from 3 study surgeons who were using ePTFE in combination with a second
material for graft material. Based on safety concerns, the Data Safety Monitoring Board
mandated that the use of ePTFE mesh be discontinued for future CARE participants. For this
analysis, two surgeon authors reviewed all foreign body adverse events inclusive of surgical
reports to confirm the nature of the surgical material complication, treatment and last known
status.
The groups were compared at baseline by age, body mass index (BMI), and prolapse stage;
subsequent analyses were not adjusted for these measures since they were similar in both
groups. Fisher's exact test is used to compare the proportion of erosions in those with a
specific material to the proportion of erosions in those not using the material; all p-values
are two-tailed. For certain data elements, totals are less than the entire sample size as not all
subjects provided completed data. Results are presented as percentages or as mean ±
standard deviation (SD); odds-ratios and their 95% confidence intervals are also presented.
Results
The original CARE cohort included 322 women who underwent sacrocolpopexy, 157
randomized concomitant Burch colposuspension and 165 to no Burch colposuspension.
Most (93%) of the CARE participants completed aspects of the two-year assessment, and
the non-completers did not differ significantly from completers. However, 74 (23%) did not
undergo a pelvic examination at 24 months. Most participants were Caucasian (93%) with a
mean age of 61±10 years (mean±SD). The majority of subjects (74%) were married and
parous with a median parity of 3. The mean BMI was 27±4.5 kg/m2 and most had a BMI
<30 (77%). Socioeconomic indicators, including level of education and type of medical
insurance, were widely distributed. Table 1 presents other demographic characteristics of the
sample.
There were 20 (6%) mesh/suture erosions reported within two years of surgery. Three of the
erosions involved suture only, while 17 had exposed mesh. The mean interval from surgery
to erosion was 313 days (range 45-744). Current smoking was more common in subjects
with mesh/suture erosion [5/20(25%) versus 18/302 (6%), OR 5.2 (CI 1.7, 16.0), p=0.009].
There were no other statistically significant demographic differences between subjects with
and without mesh/suture erosion, including estrogen status (premenopausal/replacement
therapy use) (p=0.24), diabetes (p=0.07), or prior surgery for prolapse (p=0.10).
Concurrent hysterectomy was performed in 83/322 (26%) of subjects, and was more
common in the group with mesh/suture erosion [60% versus 24%, OR 4.9 (CI 1.9, 12.4),
p=0.0009]. There was no difference in the erosion rate based on the randomized
intervention, Burch colposuspension. We did not detect an effect of mesh configuration on
mesh/suture erosion either (p=1.0). Some form of culdoplasty was used in 112 (35%), with
the Halban technique being most common, and no detected difference among erosion
groups. There was also no statistical difference in operating time, estimated blood loss, or
intraoperative and postoperative complications.
Surgeons used a variety of graft and suture materials for the ASC (Table 2). Most ASC
procedures were done with synthetic mesh (92%) with common use of woven polyester
(42%) and polypropylene (48%) and minimal use of ePFTE (6%); some were used in
different combinations. Despite the small number of participants exposed to ePFTE, we
detected a significantly higher risk of mesh erosion in women who had ePFTE mesh (alone
or in combination) compared to those without ePFTE mesh [4/21 (19%) versus 16/301
(5.3%), OR 4.2 (95% CI 1.3, 13.9), p=0.033]. A minority of subjects received two types of
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grafts 25(8%), including 9(2.8%) ePTFE/polypropylene, and 7(2.2%) ePTFE/braided
polyester. The use of ePFTE for combined graft was also associated with mesh/suture
erosion (4/17, (24%) versus 16/305, (5.2%): OR 5.6 (95% CI 1.6, 19.0)).
A wide variety of sutures were used for attachment of the grafts to the vaginal walls and
anterior longitudinal ligament of the sacrum. The mean number of sutures used for the
vaginal attachment of both grafts was 12.7 with a range of (4-22), with ePFTE suture used
most commonly for anchoring the graft to the vagina (53%). There were no associations of
mesh/suture erosion with polypropylene or polyester and while there was a trend for higher
rate of erosion with ePFTE, it was not statistically significant. (Table 2)
Two of three patients with suture erosions healed after simple removal of suture. The third
patient probably had suture erosion, but healing after suture removal has not been
confirmed. Of the remaining events, 17 were mesh erosions; 4 were managed without
surgery, of which 1 was lost to follow-up and the other 3 had no resolution. Thirteen patients
with mesh erosion underwent at least one surgery, for mesh removal. Two patients had
resolution, 6 had persistent erosions and 5 were lost to follow-up. One subject had two
partial resection procedures and one had three; both had subsequent chronic sinus tracts.
Comment
In our prospective study with standardized follow-up, 20 of 302 (6% CI 4.0 – 9.5%) of
subjects had mesh or suture erosion. This is higher than the 3.4% rate (70 of 2178) of mesh
erosions reported in a comprehensive literature review by Nygaard et al[1], but nearly the
same as the 8% rate reported in another large case series of 92 ASCs.[5] Neither of these
reviews included suture erosions. In this analysis, we included all patients with either suture
or mesh exposures, including participants who responded to non-surgical treatment of the
erosion.
The most important finding of our study is that there are modifiable surgeon and patient risk
factors that are associated with an increased risk of mesh or suture erosion. The risk of mesh
complications was nearly four-fold higher if ePTFE (Gore-Tex®) mesh was used compared
to a non- ePTFE mesh, a strong association that was noted early on in the study and altered
ePTFE use. Although only 6% of patients had their ASC performed with ePTFE material,
the 4-fold association was significantly strong and clinically relevant. Recent literature
supports our results. Begley et al [5] found high rates of colpopexy mesh erosion with
ePTFE (9%) and silicon coated mesh (19%) and a single center recently reported that 15 of
22 referred ASC mesh erosions were ePTFE.[10] Mesh erosion rates are even higher if
ePTFE is placed transvaginally; in a series of 108 ePTFE vaginal slings, Weinberger et. al
reported a 40% infection rate and 22% removal rate [11]. ePTFE mesh has been used
extensively in abdominal hernia repairs and has several unique qualities. The material is
microporous; this reduces host tissue ingrowth and adhesion formation, which is why ePTFE
can be safely placed in direct contact with the intestines. We do not fully understand the
etiology of mesh erosion, however, infection may be a contributing factor. The qualities of
ePTFE mesh reduce the accessibility of micro-organisms to antimicrobial agents and the
host immune system and can create a bacterial sanctuary. Therefore, when ePTFE becomes
infected, treatment nearly always requires the removal of the entire mesh.[12] During a
ASC, the mesh is placed abdominally under sterile conditions, but the sutures that secure the
mesh to the vagina may traverse the full thickness of the vagina and vaginal bacteria may
travel along the suture to colonize the mesh. This risk of bacterial ascension may be greater
with multifilament vaginal sutures although our study does not have sufficient power to
conclusively support or refute this theory.
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Concurrent total abdominal hysterectomy was performed in 26% of our subjects and these
subjects had a 14% risk of erosion compared to just 4% in women who had a previous
hysterectomy and, therefore, had their colpopexy performed on an intact vaginal cuff. This
five-fold increased risk of erosion with concomitant hysterectomy is consistent with data
from a retrospective review of 313 women which found a statistically significant 5-fold risk
in women on estrogen with concomitant hysterectomy.[13] In cases of mesh erosion with
concomitant hysterectomy the erosion site is nearly always at the cuff. Two theories may
explain this result. The first theory is that there is increased vaginal bacterial contamination
of the mesh from an opened vagina during hysterectomy. The second theory is that poor
healing occurs at the new cuff because of the devascularizing effects of both cuff closure
and mesh vaginal attachment sutures. For this reason, some surgeons prefer performing
supracervical hysterectomies and sacrocolpocervicopexies when hysterectomy is indicated
and normal cervical cytology has been documented.
Smoking was also associated with a five-fold increased risk of erosion and is a patient
modifiable risk factor. In a recent retrospective ASC study of 21 mesh erosions seen in 499
women there was a non-significant trend for smokers to require more than one surgery for
effective treatment of their erosions.[3] It is possible that microvascular vasospasms
associated with smoking lead to poor wound healing and vaginal mesh erosion.
Our study was not powered to analyze management of erosions and clinical decisions varied
depending on the patient's clinical presentation. Anecdotally, when only a small area of the
graft is exposed without obvious inflammatory response, a trial of transvaginal estrogen is
frequently advocated to stimulate growth of the vaginal mucosa over the exposed area.
There is minimal literature evaluating this approach, although the available evidence only
notes a 14% cure.[14] Exposed sutures may be removed in the exam room. Larger areas of
exposed mesh and any erosion with an obvious inflammatory reaction thought limited to the
area of vaginal attachment may be managed by local surgical excision, however anesthesia
is generally indicated to evaluate the extent of the mesh involvement and to allow for
whatever surgical excision and debridement is deemed necessary. This approach has a
reported efficacy of 50%.[3] When the upper portion of the mesh is infected, removal of the
entire graft is required through either a transvaginal or abdominal approach. Residual
infected mesh after a failed partial excision requires a second excision generally via
laparotomy, and usually represents a difficult surgical dilemma as recurrent erosions are
associated with chronic morbidity including chronic infection, sinus tracts, abscess and
fistula formation.[3,13]
The strength of this study is that it was prospectively designed to capture surgical and mesh/
suture erosions at regular study intervals for the first two years. We are confident that few if
any mesh erosions were not detected in women who were not lost to follow-up, although it
is possible that the 74 patients that did not have a 2-year exam could have had asymptomatic
erosions. In fact, many of these 74 subjects did have subjective follow-up by phone, and 3 of
the documented erosions were in the group without 24 month exam. Nevertheless, all of the
identified risk factors for erosion were more common in the group without a 24 month exam
then in the entire sample: smoking 11% v. 7%, concurrent hysterectomy 32% v. 26%, and
use of Gortex mesh 9% v. 6%. In fact, a third of the subjects that had Gortex mesh did not
have a 24 month exam. Consequently, it is possible that we underestimated the association
of these parameters with mesh erosion. We did not randomly assign different types of mesh
material in our study, so we cannot exclude the possible confounding effects of surgeon or
patient selection bias. However, the statistically significant associations of ePTFE mesh,
concomitant hysterectomy, and smoking were strong ones with odds ratios ranging from 4 to
5 and we feel confident in these associations; but as with all retrospective associations, this
does not prove causation.
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In summary, ePFTE mesh should not be used when performing ASC. Concurrent
hysterectomy and smoking are modifiable risks for mesh/suture erosion.
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Table 1
Selected demographic and surgical variables of subjects undergoing colpopexy (n=322)
n (%)
Diabetes 16 (5.0%)
Smoking Current 23 (7.2%)
Estrogen status Premenopausal/ERT 162 (50.9%)
Postmenopausal 156 (49.1%)
Prior Surgery for Incontinence 22 (6.8%)
Prior Surgery for Prolapse 126(39.1%)










Graft configuration Conical 12 (3.7%)
Two strap 182 (56.5%)
Y configuration 121 (37.6%)
Fingered 2(0.6%)
Other 5(1.6%)
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